Myoclonic status in nonprogressive encephalopathies: An update
Open Access
- 4 May 2009
- Vol. 50 (s5), 41-44
- https://doi.org/10.1111/j.1528-1167.2009.02119.x
Abstract
Myoclonic status in nonprogressive encephalopathies (MSNE) is an epileptic syndrome in development, characterized by the early onset of continuous diffuse epileptiform abnormalities, accompanied by positive and/or negative phenomena correlated with transient and recurring motor, cognitive, or behavioral disturbances. Outcome of MSNE is poor and may determine progressive neurologic deterioration. MSNE is not easy to recognize and should be distinguished from progressive myoclonic epilepsies and other rarely reported infantile myoclonic epilepsies. The identification of MSNE may guide the diagnostic work-up, suggesting the presence of a genetic defect, such as Angelman syndrome, hypoxic-ischemic encephalopathy, or brain malformation.Keywords
This publication has 9 references indexed in Scilit:
- Myoclonic Status in Nonprogressive Encephalopathies: Study of 29 CasesEpilepsia, 2006
- Report of the ILAE Classification Core GroupEpilepsia, 2006
- A Proposed Diagnostic Scheme for People with Epileptic Seizures and with Epilepsy: Report of the ILAE Task Force on Classification and TerminologyEpilepsia, 2001
- Phenotype–genotype correlation in 20 deletion and 20 non-deletion Angelman syndrome patientsEuropean Journal of Human Genetics, 1999
- Angelman syndrome: Correlations between epilepsy phenotypes and genotypesAnnals of Neurology, 1998
- Early-onset progressive encephalophathy with migrant, continuous myoclonusChild's Nervous System, 1996
- Migrating Partial Seizures in Infancy: A Malignant Disorder with Developmental ArrestEpilepsia, 1995
- Myoclonic Epilepsies of ChildhoodNeuropediatrics, 1971
- Minor epileptic statusJournal of the Neurological Sciences, 1966